Polymer-functionalized nanoparticles: From stealth viruses to biocompatible quantum dots

Nanomedicine

Volumn 4, Issue 8, 2009, Pages 951-966

  Jia, H ^a   Titmuss, S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adenovirus; Biocompatibility; Drug delivery; Gene therapy; Gold colloid; Magnetic nanoparticle; Nanoparticle functionalization; Polymer brush; Quantum dot

Indexed keywords

ADENOVIRUS VECTOR; GLYCOPROTEIN; GOLD NANOPARTICLE; HYBRID NANOPARTICLE; NANOPARTICLE; POLYMER; POLYSACCHARIDE; QUANTUM DOT; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; CELL AGGREGATION; CELL MEMBRANE; CHEMICAL ANALYSIS; CHEMICAL BINDING; CONFORMATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ESTERIFICATION; GENE THERAPY; MATERIAL COATING; NANOMEDICINE; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW;

HUMANS; NANOPARTICLES; NANOTECHNOLOGY; POLYMERS; QUANTUM DOTS; VIRUSES;

EID: 73349115907     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.09.81     Document Type: Review

References (125)

1. Ferrari M: Nanovector therapeutics. Curr. Opin. Chem. Biol. 9, 343-346 (2005).
2. Sanhai WR, Sakamoto JH, Canady R, Ferrari M: Seven challenges for nanomedicine. Nat. Nanotechnol. 3, 242-244 (2008).
3. Jiang W, Kim BYS, Rutka JT, Chan WCW: Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 3, 145-150 (2008). ■■ Elegant demonstration of how size affects the uptake of herceptin-coated gold nanoparticles. Greatest uptake is found for 40 nm diameter particles, which are comparable in size to many viruses.
4. Ferrari M: Beyond drug delivery. Nat. Nanotechnol. 3, 131-132 (2008).
5. Collins SA, Guinn BA, Harrison PT, Scallan MF, O'Sullivan GC, Tangney M: Viral vectors in cancer immunotherapy: which vector for which strategy? Curr. Gene Ther. 8, 66-78 (2008).
6. McConnell MJ, Imperiale MJ: Biology of Adenovirus and its use as a vector for gene therapy. Hum. Gene Ther. 15, 1022-1033 (2004). ■ Useful, short review summarizing the biology of adenovirus and its use as a vector in gene therapy.
7. Mizuguchi H, Hayakawa T: Targeted adenovirus vectors. Hum. Gene Ther. 15, 1034-1044 (2004).
8. Lindholm L, Henning P, Magnusson MK: Novel strategies in tailoring human adenoviruses into therapeutic cancer gene therapy. vectors. Future Virol. 3, 45-59 (2008).
9. Campos SK, Barry MA: Current advances and future challenges in adenoviral vector biology and targeting. Curr. Gene Ther. 7, 189-204 (2007).
10. Ghosh SS, Gopinath P, Ramesh A: Adenoviral vectors - a promising tool for gene therapy. Appl. Biochem. Biotechnol. 133, 9-29 (2006).
11. Kanerva A, Hemminki A: Adenoviruses for treatment of cancer. Ann. Med. 37, 33-43 (2005).
12. Kaplan JM: Adenovirus-based cancer gene therapy. Curr. Gene Ther. 5, 595-605 (2005).
13. Mintzer MA, Simanek EE: Non-viral vectors for gene transfer. Chem. Rev. 109, 259-302 (2009).
14. Gao H, Shi W, Freund LB: Mechanics of receptor-mediated endocytosis. Proc. Natl Acad. Sci. USA 102, 9469-9474 (2005).
15. Osaki F, Kanamori T, Sando S, Sera T, Aoyama Y: A quantum dot conjugated sugar ball and its cellular uptake on the size effects of endocytosis in the subviral region. J. Am. Chem. Soc. 126, 6520-6521 (2004). ■ Careful experimental study of how the size of quantum dots affects uptake by cells.
16. Lopez CF, Nielsen SO, Morore PB, Klein ML: Understanding natures' design for a nanosyringe. Proc. Natl. Acad. Sci. USA 101, 4431-4434 (2004).
17. Pantarotto D, Singh R, McCarthy D et al.: Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew. Chem. Int. Ed. 43, 5242-5246 (2004).
18. te Velthuis AJW: Large virus for an even bigger task: can mimivirus close the gene-therapy vector void? Future Virol. 4, 231-239 (2009).
19. Fuschiotti P, Schoehn G, Fender P et al.: Structure of the dodecahedral pento particle from human adenovirus type 3. J. Mol. Biol. 356, 510-520 (2006).
20. Champion JA, Mitragotri S: Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. USA 103, 4930-4934 (2006).
21. Geng Y, Dalhaimer P, Cai S et al.: Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2, 249-255 (2007).
22. Decuzzi P, Ferrari M: The receptor-mediated endocytosis of nonspherical particles. Biophys. J. 94, 3790-3797 (2008).
23. Murphy CJ, Gole AM, Stone JW et al.: Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res. 41, 1721-1730 (2008).
24. Zahr AS, Pishko MV: Nanotechnology in Drug Delivery. de Villier MM, Aramwit P, Kwon GS (Eds). Springer, NY, USA (2009).
25. Israelachvili JN: Intermolecular and Surface Forces. Academic Press, NY, USA (1992).
26. Liang Y, Hilal N, Langston P, Starov V: Interaction forces between colloidal particles in liquid: theory and experiment. Adv. Colloid Interface Sci. 134-135, 151-166 (2007).
27. Witten TA: Insights from soft condensed matter. Rev. Mod. Phys. 71, S367-S373 (1999).
28. de Gennes PG: Soft matter. Nobel Lecture 1991, 8-14 (1999).
29. Shaw I: Ancient Egyptian Materials and Technology. Nicholson PT, Shaw I (Eds). Cambridge University Press, Cambridge, UK (2000).
30. Pasquato L, Pengo P, Scrimin P: Biological and biomimetic applications of nanoparticles. In: Building Blocks for Nanotechnology. Rotello VM (Ed.). Kluwer Academic/Plenum Publishers, NY, USA, 251-282 (2003).
31. Liu, WT: Nanoparticles and their biological and environmental applications. J. Biosci. Bioeng. 102, 1-7 (2006).
32. Rubinstein M, Colby RH: Polymer Physics. Oxford University Press, Oxford, UK (2003).
33. Bandyopadhyaya R, Nativ-Roth E, Regev O, Yerushalmi-Rosen R: Stabilization of individual carbon nanotubes in aqueous solutions. Nano Lett. 2, 25-28 (2002).
34. Toomey R, Tirrell M: Functional polymer brushes in aqueous media from self-assembled and surface-initiated polymers. Annu. Rev. Phys. Chem. 59, 493-517 (2008). ■ Recent review that updates the status of the theory of polymer brushes to include nonclassical effects that are relevant to modern experimental studies.
35. Halperin A: Polymer brushes that resist adsorption of model proteins: design parameters. Langmuir 15, 2525-2533 (1999).
36. Jeon SL, Lee JH, Andrade JD, de Gennes PG: Protein-surface interactions in the presence of polyethylene oxide. J. Colloid Interface Sci. 142, 149-166 (1991). ■ Elegant and insightful theoretical approach to explain why polymer brush functionalization might confer protein-binding resistance on interfaces.
37. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA: Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl Acad. Sci. USA 105, 14265-14270 (2008).
38. Titmuss S, Briscoe WH, Dunlop IE, Sakellariou G, Hadjichristidis N, Klein J: Effect of end-group sticking energy on the properties of polymer brushes: comparing experiment and theory. J. Chem. Phys. 121, 11408-11419 (2004).
39. Ruckenstein E, Li ZF: Surface modifiction and functionalization through the self-assembled monolayer and graft polymerization. Adv. Colloid Interface Sci. 113, 43-63 (2005).
40. Noguchi H, Gomper G: Shape transitions of fluid vesicles and red blood cells in capillary flows. Proc. Natl Acad. Sci. USA 102, 14159-14164 (2005).
41. Grest GS: Normal and shear forces between polymer brushes. In: Advances in Polymer Science. Granick S (Ed.). Springer, Berlin, Germany (1999).
42. Eto Y, Yoshioka Y, Mukai Y, Okada N, Nakagawa S: Development of PEGylated adenovirus vector with targeting ligand. Int. J. Pharm. 354, 3-8 (2008).
43. Tsujii Y, Ohno K, Yamamoto S, Goto A, Fukada T: Structure and properties of high density polymer brushes prepared by surface-initiated living radical polymerization. Adv. Polym. Sci. 197, 1-45 (2006). ■ Comprehensive review of how the properties of polymer brushes vary as the high grafting densities are reached in surface-initiated polymerizations.
44. Senaratne W, Andruzzi L, Ober CK: Self-assembled monolayers and polymer brushes in biotechnology: current applications and future perspectives. Biomacromolecules 6, 2427-2448 (2005).
45. Edmondson S, Osbourne VL, Huck WTS: Polymer brushes via surface-initiated polymerizations. Chem. Soc. Rev. 33, 14-22 (2004). ■■ Tutorial-style review of the chemistry of surface-initiated polymerizations.
46. Advincula RC: Surface initiated polymerization from nanoparticle surfaces. J. Dispers. Sci. Technol. 24, 343-361 (2003).
47. Hunag WX, Skanth G, Baker GL, Bruening ML: Surface-initiated thermal radical polymerization on gold. Langmuir 17, 1731-1736 (2001).
48. Rexroad J, Evans RK, Middaugh CR: Effect of pH and ionic strength on the physical stability of adenovirus type 5. J. Pharm. Sci. 95, 237-247 (2006).
49. Rexroad J, Martin TT, McNeilly D, Godwin S, Middaugh CR: Thermal stability of adenovirus type 2 as a function of pH. J. Pharm. Sci. 95, 1469-1474 (2006).
50. Minko S: Responsive polymer brushes. Polymer Rev. 46, 397-420 (2006).
51. Vo C-D, Schmid A, Armes SP: Surface ATRP of hydrophilic monomers from ultrafine aqueous silica sols using anionic polyelectrolytic macroinitiators. Langmuir 23, 408-413 (2007).
52. Chen X, Armes SP, Greaves SJ, Watts JF: Synthesis of hydrophilic polymer-grafted ultrafine inorganic oxide particles in protic media at ambient temperature via atom transfer radical polymerization: use of an electrostatically adsorbed polyelectrolytic macroinitiator. Langmuir 20, 587-595 (2004).
53. Edmondson S, Vo C-D, Armes SP, Unali G-F: Surface polymerization from planar surfaces by atom transfer radical polymerization using polyelectrolytic macroinitiators. Macromolecules 40, 5271-5278 (2007).
54. Ballauf M: Spherical polyelectrolyte brushes. Prog. Polym. Sci. 32, 1135-1151 (2007).
55. Netz R, Andelman D: Neutral and charged polymers at interfaces. Phys. Rep. 380, 1-95 (2003).
56. Naji A, Seidel C, Netz RR: Theoretical approaches to neutral and charged polymer brushes. Adv. Polym. Sci. 198, 149-183 (2006).
57. Kim JU, Matsen MW: Interaction between polymer-grafted particles. Macromolecules 41, 4435-4443 (2008).
58. Roan J-R: Attraction between nanoparticles induced by end-grafted homopolymers in good solvent. Phys. Rev. Lett. 86, 1027-1030 (2001).
59. Schaeffer DV, Koerber JT, Lim K: Molecular engineering of viral gene delivery vehicles. Annu. Rev. Biomed. Eng. 10, 169-194 (2008).
60. Majhen D, Ambriovic-Ristov A: Adenoviral vectors - how to use them in cancer gene therapy. Virus Res. 119, 121-133 (2006).
61. Gardlik R, Palfy R, Hodosy J, Lukacs J, Turna J, Celec P: Vectors and delivery systems in gene therapy. Med. Sci. Monit. 11, RA110-RA121 (2005).
62. Tatsis N, Ertl HCJ: Adenovirus as vaccine vectors. Mol. Ther. 10, 619-629 (2004).
63. Rux JJ, Burnett RM: Adenovirus structure. Hum. Gene Ther. 15, 1167-1176 (2004).
64. Carlisle RC, Di Y, Cerny AM et al.: Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood 113, 1909-1918 (2009).
65. Fisher KD, Stallwood Y, Green NK, Ulbrich K, Mautner V, Seymour LW: Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther. 8, 341-348 (2001). ■■ Clear experimental demonstration of how polymer coating of adenovirus confers stealth and facilitates efficient retargeting to make it a useful vector for gene therapy.
66. Harris JM, Chess RB: Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2, 214-221 (2003).
67. Prencipe G, Tabakman SM, Welsher K et al.: PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J. Am. Chem. Soc. 131, 4783-4787 (2009).
68. Fisher KD, Green NK, Hale A et al.: Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy. J. Drug Target. 15, 546-551 (2007).
69. Stevenson M, Boos E, Herbert C et al.: Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells. Gene Ther. 13, 356-368 (2006).
70. Briggs SS, Fisher KD, Seymour LW: Starburst virus - antibody resistant therapeutic viruses. Hum. Gene Ther. 19, 417 (2008).
71. Daniel M-C, Astruc D: Gold nanoparticles: assembly, supramolecular chemistry, quantumsize-related properties, and applications toward biology, caltalysis, and nanotechnology. Chem. Rev. 104, 293-346 (2004).
72. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA: Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J. Phys. Chem. B 110, 7238-7248 (2006).
73. Dahmen C, von Plessen G: Optical effects of metallic nanoparticles. Aust. J. Chem. 60, 447-456 (2007).
74. Moores A, Goettmann F: The plasmon band in noble metal nanoparticles: an introduction to theory and applications. New J. Chem. 30, 1121-1132 (2006).
75. Khlebtsov NG, Trachuk LA, Mel'nikov AG: The effect of the size, shape, and structure of metal nanoparticles on the dependence of their optical properties on the refractive index of a disperse medium. Opt. Spectros. 98, 77-83 (2005).
76. Nehl CL, Hafner JH: Shape-dependent plasmon resonances of gold nanoparticles. J. Mater. Chem. 18, 2415-2419 (2008).
77. Ghosh SK, Pal T: Interparticle coupling effect on the surface plasmon resonance of gold nanoparticles: from theory to applications. Chem. Rev. 107, 4797-4862 (2007).
78. Perez-Juste J, Pastoriza-Santos I, Liz-Marzan LM, Mulvaney P: Gold nanorods: synthesis, characterization and applications. Coord. Chem. Rev. 249, 1870-1901 (2005).
79. Nam JM, Thaxton CS, Mirkin CA: Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301, 1884-1886 (2003).
80. Elghanian R, Storhoff JJ, Mucic RC, Letsinger RL, Mirkin CA: Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 277, 1078-1081 (1997).
81. Jain PK, Huang X, El-Sayed IH, El-Sayed MA: Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology and medicine. Acc. Chem. Res. 41, 1578-1586 (2008).
82. Liao H, Nehl CL, Hafner JH: Biomedical applications of plasmon resonant metal nanoparticles. Nanomedicine 1, 201-208 (2006).
83. White KA, Rossi NL: Gold nanoparticle-based arrays for the detection of biologically relevant molecules. Nanomedicine 3, 543-553 (2008).
84. You CC, Miranda OR, Gider B et al.: Detection and identification of proteins using nanoparticle-fluorescent polymer 'chemical nose' sensors. Nat. Nanotechnol. 2, 318-323 (2007).
85. Eck W, Craig G, Sigdel A et al.: PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. ACS Nano 2, 2263-2272 (2008).
86. Cheng Y, Samia AC, Meyers JD, Panagopoulos I, Fei BW, Burda C: Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J. Am. Chem. Soc. 130, 10643-10647 (2008).
87. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL: Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 209, 171-176 (2004).
88. Pitsillides CM, Joe EK, Wei XB, Anderson RR, Lin CP: Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys. J. 84, 4023-4032 (2003).
89. Li DX, He QA, Li JB: Smart core/shell nanocomposites: intelligent polymers modified gold nanoparticles. Adv. Colloid Interface Sci. 149, 28-38 (2009).
90. Kim JH, Lee TR: Discrete thermally responsive hydrogel-coated gold nanoparticles for use as drug delivery vehicles. Drug Dev. Res. 67, 61-69 (2006).
91. Plunkett KN, Zhu X, Moore JS, Leckband DE: PNIPAM chain collapse depends on the molecular weight and grafting density. Langmuir 22, 4259-4266 (2006).
92. Yim H, Kent MS, Mendez S, Lopez GP, Satija S, Seo Y: Effects of grafting density and molecular weight on the temperature dependent conformational change of poly(N-isopropylacrylamide) grafted chains in water. Macromolecules 39, 3420-3426 (2006).
93. Zhang T, Zheng Z, Ding X, Peng Y: Smart surface of gold nanoparticles fabricated by combination of RAFT and Click chemistry. Macromol. Rapid Comm. 29, 1716-1720 (2008).
94. Owens DE, Eby JK, Jian Y, Peppas NA: Temperature-responsive polymer-gold nanocomposites as intelligent therapeutic systems. J. Biomed. Mater. Res. 83A, 692-695 (2007).
95. Duan H, Kuang M, Wang D, Kurth DG, Mohwald H: Colloidally stable amphibious nanocrystals derived from poly{[2-(dimethylamino)ethyl] methacrylate} capping. Angew. Chem. Int. Ed. 44, 1717-1720 (2005).
96. Yuan JJ, Schmid A, Armes SP, Lewis AL: Facile synthesis of highly biocompatible poly(2-(methacryloxy)ethyl phosphorylcholine)-coated gold nanoparticles in aqueous solution. Langmuir 22(26), 11022-11027 (2006).
97. Kirchner C, Liedl T, Kudera S et al.: Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett. 5, 331-338 (2005).
98. Hauck TS, Ghazani AA, Chan WCW: Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 4, 153-159 (2008).
99. Gao XH, Cui YY, Levenson RM, Chung LWK, Nie SM: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22, 969-976 (2004).
100. Wang M, Felorzabihi N, Guerin G, Haley JC, Scholes GD, Winnik MA: Water soluble CsSe quantum dots passivated by a multidentate diblock copolymer. Macromolecules 40, 6377-6384 (2007).
101. Zhou L, Gao C, Xu WJ: Amphibious polymer-functionalized CdTe quantum dots: synthesis, thermoresponsive self-assembly and photoluminescent properties. J. Mater. Chem. 19, 5655-5664 (2009).
102. Tan WB, Zhang Y: Surface modification of gold and quantum dot nanoparticles with chitosan for bioapplications. J. Biomed. Mater. Res. 75A, 56-62 (2005).
103. Howarth M, Liu WH, Puthenveetil S et al.: Monovalent, reduced-size quantum dots for imaging receptors on living cells. Nat. Methods 5, 397-399 (2008).
104. Liu W, Howarth M, Greytak AB et al.: Compact biocompatible quantum dots functionalized for cellular imaging. J. Am. Chem. Soc. 130, 1274-1284 (2008).
105. Senyei A, Widder K, Czerlinski G: Magnetic guidance of drug-carrying microspheres. J. Appl. Phys. 49, 3578-3583 (1978).
106. Mosbach K, Schroder U: Preparation and application of magnetic polymers for targeting of drugs. FEBS Lett. 102, 112-116 (1979).
107. Lu AH, Salabas EL, Schuth F: Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 46, 1222-1244 (2007).
108. Huber DL: Synthesis, properties, and applications of iron nanoparticles. Small 1, 482-501 (2005).
109. Pankhurst QA, Connolly J, Jones SK, Dobson J: Applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 36, R167-R181 (2003).
110. Dobson J: Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther. 13, 283-287 (2006).
111. Jain TK, Moralles MA, Sahoo SK, Lesllie-Pellecky DL, Labhasetwar V: Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm. 2, 194-205 (2005).
112. Bae KH, Ha YJ, Kim C, Lee KR, Park TG: Pluronic/chitosan shell crosslinked nanocapsules encapsulating magnetic nanoparticles. J. Biomater. Sci. 19, 1571-1583 (2008).
113. Lee H, Lee E, Kim DK, Jang NK, Jeong YY, Jon S: Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J. Am. Chem. Soc. 128, 7383-7389 (2006).
114. Liu T-Y, Hu S-H, Liu D-M, Chen S-Y, ChenI-W: Biomedical nanoparticle carriers with combined thermal and magnetic responses. Nano Today 4, 52-63 (2009).
115. Duncan R: Targeting and intracellular delivery of drugs. In: Encyclopedia of Molecular Cell Biology and Molecular Medicine. Meyer RA (Ed.). Wiley-VCH, Weinheim, Germany (2005).
116. Duncan R, Kreyling WG, Boisseau P et al.: Forward Look for Nanomedicine. ESF Policy Briefing, Strasbourg, France (2005).
117. Loo L, Guenther RH, Basnayake VR, Lommel SA, Franzen S: Controlled encapsidation of gold nanoparticles by a viral protein shell. J. Am. Chem. Soc. 128, 4502-4503 (2006).
118. Slocik, J: Viral templates for gold nanoparticle synthesis. J. Mater. Chem. 15, 749-753 (2005).
119. Chen C, Daniel M-C, Quinkert ZT et al.: Nanoparticle-templated assembly of viral protein cages. Nano Lett. 6, 611-615 (2006).
120. Goicochea NL, De M, Rotello VM, Mukhopadhyay S, Dragnea B: Core-like particles of an enveloped animal virus can self-assemble efficiently on artificial templates. Nano Lett. 6, 2281-2290 (2007). ■■ Elegant experimental study of the assembly of a viral capsid around gold nanoparticles that could form the basis of future nanomedicines.
121. Everts M, Saini V, Leddon JL et al.: Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy. Nano Lett. 6, 587-591 (2006).
122. Morishita N, Nakagami H, Morishita R et al.: Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem. Biophys. Res. Commun. 334, 1121-1126 (2005).
123. Merlitz H, He G-L, Wu C-X, Sommer J-U: Nanoscale brushes: how to build a smart surface coating. Phys. Rev. Lett. 102, 115702 (2009).
124. Gupta SS, Raja KS, Kaltgrad E, Strable E, Finn MG: Virus-glycopolymer conjugates by copper(I) catalysis of atom transfer radical polymerization and azide-alkyne cycloaddition. Chem. Comm. 34, 4315-4317 (2005).
125. Kaltgard E, O'Reilly MK, Liao L, Han S, Paulson JC, Finn MG: On-virus construction of polyvalent glycan ligands for cell-surface receptors. J. Am. Chem. Soc. 130, 4578-4579 (2008).